Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Mycophenolate mofetil Teva

Mycophenolate mofetil Teva 250 mg hard capsules · Abschnitt 4.8 · PDF-Seite 13–14

HOS-209353 · Präparat HOS-154301

13  Adverse reaction Renal transplant Hepatic transplant Cardiac transplant (MedDRA) System Organ Class Frequency Frequency Frequency Immune system disorders Hypersenstivity Uncommon Common Common Hypogammaglobulinaemia Uncommon Very rare Very rare Anaphylactic reactions Not known Not known Not known Hepatobiliary disorders Blood alkaline phosphatase Common Common Common increased Blood lactate dehydrogenase Common Uncommon Very common increased Hepatic enzyme increased Common Very common Very common Hepatitis Common Very common Uncommon Hyperbilirubinaemia Common Very common Very common Jaundice Uncommon Common Common Skin and subcutaneous tissue disorders Acne Common Common Very common Alopecia Common Common Common Rash Common Very common Very common Skin hypertrophy Common Common Very common Musculoskeletal and connective tissue disorders Arthralgia Common Common Very common Muscular weakness Common Common Very common Renal and urinary disorders Blood creatinine increased Common Very common Very common Blood urea increased Uncommon Very common Very common Haematuria Very common Common Common Renal impairment Common Very common Very common General disorders and administration site conditions Asthenia Very common Very common Very common Chills Common Very common Very common Oedema Very common Very common Very common Hernia Common Very common Very common Malaise Common Common Common Pain Common Very common Very common Pyrexia Very common Very common Very common De novo purine synthesis Uncommon Uncommon Uncommon inhibitors-associated acute inflammatory syndrome

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.